[ad_1]
Global market for diagnosis and treatment of allergies
The increasing availability of effective treatment options is a major factor in the growth of the diagnostic and allergy treatment market. Overall, revenue from the $ 1 billion diagnostic and treatment market for allergies is expected to grow at a steady pace over the forecast period (2016-2024). While the government is taking key steps to improve health facilities, many private players have emerged in the healthcare market to optimize and revolutionize the health sector. These macro-health factors are expected to stimulate growth in various health sector markets, including the allergy diagnostic market.
Get an example of an exclusive report on: bit.ly/2tGEANJ
Allergy is a form of medical hypersensitivity of the immune system when the system reacts to a foreign substance (allergen). Symptoms of allergy include runny nose, redness of the eyes, itching, hives, eczema or, more importantly, an asthma attack. In a similar context, allergy diagnostic services are used to identify the type of allergy and, accordingly, to determine the treatment regimen of allergic conditions. In addition, with the merger of advanced technologies in the field of on-site diagnostics, the allergy diagnostic and treatment market is expected to grow significantly in the near future.
Key players worldwide:
BioMérieux, Danaher Corporation, GlaxoSmithKline plc, Hitachi Chemical Diagnostics, Inc., Merck & Co., Inc., Omega Diagnostics Group PLC, Siemens Healthcare, Thermo Fisher Scientific, Inc..
Taxonomy of the market for the treatment and diagnosis of allergies:
Consistent market information has segmented the market on the basis of
Allergy Type, Tests Completed, Medication, End Use
Based on the type of allergy, the market scenario of the diagnosis and treatment of allergy can be segmented as follows:
Drug Allergy, Allergic Rhinitis, Food Allergy, Cutaneous Allergy, Insect Allergy, Sinusitis, General Allergy
Sinusitis and food allergies are particularly prevalent in developed regions.
The drug allergy segment is expected to experience double-digit growth between 2016 and 2024.
Some of the main diagnostic tests performed to detect allergy types are:
Antihistamines, Decongestants, Corticosteroids, Leukotriene Inhibitors, Mast Cell Inhibitors, Other
On the basis of drugs, the market for the diagnosis and treatment of allergies is segmented into
Antihistamines, Decongestants, Corticosteroids, Leukotriene Inhibitors, Mast Cell Inhibitors, Other
Browse the research report on: bit.ly/2VpW4cS
Increased awareness of preventative measures should boost sales in the allergies diagnosis and treatment market:
A high incidence of allergic diseases such as allergic rhinitis, asthma, sinusitis, food allergy and other respiratory allergies is expected to stimulate the growth of the market for the diagnosis and treatment of l & 39; allergy in the near future. For example, according to the WHO, more than 300 million patients were asthmatics worldwide in 2013 and are expected to reach more than 400 million by 2025. In addition, according to statistics provided by the WHO, American Academy of Allergies, Asthma and Immunology, about% of the population are suffering from allergic rhinitis.
The growing prevalence of allergies among the world's population is expected to lead to growth in the global market for the diagnosis and treatment of allergies. In addition, growing government support for the development of new treatments and vaccines, as well as the high number of research and development initiatives for the development of advanced diagnostic techniques, should fuel the growth of this market. in the near future. Technological advances in the field of in vitro diagnostics and increasing attention to maintaining a higher quality of life are some of the factors that should contribute to the growth of this market over the forecast period. However, the high cost of these tests and the unavailability of test kits are among the factors that should negatively influence the growth of this market.
North America and Europe should dominate the global market for allergy diagnosis and treatment:
North America, followed by Europe, generated the largest share of the diagnostic and allergy treatment market revenue, mainly because of the high incidence of allergic diseases in the United States. United. According to a study conducted by the Centers for Disease Control and Prevention in 2013, between 1997 and 2011, food allergies in children increased by about 50%. In addition, according to the European Academy of Allergy and Clinical Immunology (EAACI), more than 17 million people in Europe were affected by a food allergy in 2015.
Get instant rebate | Contact us at: bit.ly/2U8lnQI
About consistent market badysis:
Coherent Market Insights is a leading market research and advisory firm that provides ready-made underwritten research reports, customized market research, advisory services and competitive badysis in the form of a variety of recommendations. emerging market trends, technologies and potential opportunities in absolute dollars.
Contact us:
Mr. Shah
Coherent market overview
1001 4th Ave,
# 3200
Seattle, WA 98154
Tel: + 1-206-701-6702
Email: [email protected]
This press release was published on openPR.
Source link
